Skip to main contentSkip to main content

FOXO4-DRI Testing Services

FOXO4-DRI is a D-retro-inverso modified peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. It has gained attention in senolytic research for its ability to selectively eliminate aged cells in preclinical studies.

Research Applications

Common research areas for FOXO4-DRI

  • Senolytic research
  • Aging and cellular senescence
  • FOXO-p53 pathway studies
  • Longevity research

Peptide Information

Molecular details and sample requirements

Sequence / Structure:

D-retro-inverso FOXO4 peptide (modified)

Molecular Weight

~5500 g/mol

Formula

Modified peptide

Recommended Purity

≥95%

Sample Size

1-2 mg lyophilized

Our FOXO4-DRI Testing Services

Comprehensive analytical testing to ensure FOXO4-DRI quality and purity

Ready to test your peptides?

Send your peptide name, sample count, and the tests you need. We return a fixed-price quote, usually within one business day.

  • validated analytical methods, independent of any supplier
  • 9-11 business day standard turnaround
  • Traceable COA with chromatograms and method parameters

FOXO4-DRI Testing Methodology

Our analytical workflow for FOXO4-DRI follows USP <1225> guidance for validated chromatographic methods. Each lot is processed by a credentialed analyst with documented chain of custody.

  1. Step 1

    Sample intake & chain of custody

    Your FOXO4-DRI sample (1-2 mg lyophilized) is logged at our Florida lab with a unique ID, photographed, and stored at -20 °C until analysis.

  2. Step 2

    Reverse-phase HPLC purity

    FOXO4-DRI is dissolved in mobile phase and run on a C18 column with a water/acetonitrile gradient containing 0.1% TFA. UV detection at 214 nm quantifies the main peak and any related impurities.

  3. Step 3

    LC-MS identity confirmation

    An aliquot is analyzed by liquid chromatography-mass spectrometry. The observed monoisotopic mass is compared against the theoretical molecular weight (~5500 g/mol) for FOXO4-DRI to confirm identity.

  4. Step 4

    Impurity profiling & reporting

    Related substances, truncations, and oxidation products are quantified. Findings are compiled into a signed Certificate of Analysis with chromatograms, mass spectra, and analyst interpretation.

FOXO4-DRI Purity Notes

Recommended research-grade purity for FOXO4-DRI is ≥95%. Lot-to-lot variation is common with solid-phase synthesis, so independent verification matters.

Common impurities to watch

  • Truncated sequences from incomplete coupling
  • Deletion peptides missing one or more residues
  • Oxidation of methionine, tryptophan, or cysteine
  • Residual TFA, acetate, or solvent counter-ions
  • Aggregates and dimers from improper storage

What our COA confirms

  • Main peak purity by HPLC area %
  • Observed vs theoretical mass (~5500 g/mol)
  • Named impurities ≥ 0.1% area
  • Net peptide content where applicable
  • Method, column, and instrument metadata

FOXO4-DRI Handling, Storage & Safety

Guidance below is for laboratory and research personnel only. FOXO4-DRI is supplied for research use and is not intended for human or veterinary use.

Storage

Store lyophilized FOXO4-DRI at -20 °C, protected from light and moisture. After reconstitution, aliquot and store at -80 °C; avoid repeated freeze-thaw cycles.

Reconstitution

Reconstitute in bacteriostatic or sterile water in a clean environment. Allow vials to reach room temperature before opening to prevent moisture condensation on the powder.

PPE & shipping

Handle with gloves, lab coat, and eye protection. Ship samples to ACS overnight on dry ice or cold packs in a rigid, leak-proof container with a packing slip referencing your quote.

This page is informational and does not constitute medical advice. Consult your institution's safety officer and SDS before working with FOXO4-DRI.

Get Your FOXO4-DRI Tested Today

Contact us for a detailed quote and learn how our US laboratory COA can verify your FOXO4-DRI quality

People Also Ask: FOXO4-DRI Testing